SpringerLink
Log in

Breast Cancer Health Disparities in Hispanics/Latinas

  • Breast Cancer Disparities (LA Newman, Section Editor)
  • Published:
Current Breast Cancer Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Breast cancer incidence and mortality rates are lower in some Hispanic/Latino subpopulations compared with non-Hispanic White women. However, studies suggest that the risk of breast cancer–specific mortality is higher in USA Hispanics/Latinas. In this review we summarized current knowledge on factors associated with breast cancer incidence and risk of mortality in women of Hispanic/Latino origin.

Recent Findings

Associative studies have proposed a multiplicity of factors likely contributing to differences in breast cancer incidence and survival between population groups, including socioeconomic/sociodemographic factors and lifestyle choices as well as access to and quality of care. Reports of association between global genetic ancestry overall as well as subtype-specific breast cancer risk among Hispanic/Latinas suggest that incidence and subtype distribution could result from differential exposure to environmental and lifestyle-related factors correlated with genetic ancestry as well as germline genetic variation.

Summary

Hispanic/Latinos in the USA have been largely underrepresented in cancer research. It is important to implement inclusive programs that facilitate the access of this population to health services and that also include education programs for the community on the importance of screening. In addition, it is important to continue promoting the inclusion of Hispanics/Latinos in genomic studies that allow understanding the biological behavior of this disease in the context of all human genetic diversity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (Spain)

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492This is the most recent report from Globocan on cancer statistics worldwide.

    Article  PubMed  Google Scholar 

  2. DeSantis CE, Ma J, Gaudet MM, Newman LA, Miller KD, Goding Sauer A, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–51. https://doi.org/10.3322/caac.21583.

    Article  PubMed  Google Scholar 

  3. Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, et al. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. J Natl Cancer Inst. 2005;97(6):439–48. https://doi.org/10.1093/jnci/dji064.

    Article  PubMed  Google Scholar 

  4. Fejerman L, Chen GK, Eng C, Huntsman S, Hu D, Williams A, et al. Admixture map** identifies a locus on 6q25 associated with breast cancer risk in US Latinas. Hum Mol Genet. 2012;21(8):1907–17. https://doi.org/10.1093/hmg/ddr617.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. • Fejerman L, Ahmadiyeh N, Hu D, Huntsman S, Beckman KB, Caswell JL, et al. Genome-wide association study of breast cancer in Latinas identifies novel protective variants on 6q25. Nat Commun. 2014;5:5260. https://doi.org/10.1038/ncomms6260This is the first GWAS of breast cancer in Latinos and reported an Indigenous American–specific protective variant located near theESR1gene.

    Article  CAS  PubMed  Google Scholar 

  6. Hoffman J, Fejerman L, Hu D, Hunstman S, Li M, John E, et al. Identification of novel common breast cancer risk variants in Latinas at the 6q25 locus. bioRxiv. 2018.

  7. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. https://doi.org/10.3322/caac.21551.

    Article  PubMed  Google Scholar 

  8. Miller KD, Goding Sauer A, Ortiz AP, Fedewa SA, Pinheiro PS, Tortolero-Luna G, et al. Cancer statistics for Hispanics/Latinos, 2018. CA Cancer J Clin. 2018;68(6):425–45. https://doi.org/10.3322/caac.21494.

    Article  PubMed  Google Scholar 

  9. DeSantis CE, Ma J, Goding Sauer A, Newman LA, Jemal A. Breast cancer statistics, 2017, racial disparity in mortality by state. CA Cancer J Clin. 2017;67(6):439–48. https://doi.org/10.3322/caac.21412.

    Article  PubMed  Google Scholar 

  10. Yedjou CG, Tchounwou PB, Payton M, Miele L, Fonseca DD, Lowe L, et al. Assessing the racial and ethnic disparities in breast cancer mortality in the United States. Int J Environ Res Public Health. 2017;14(5):E486. https://doi.org/10.3390/ijerph14050486.

    Article  CAS  PubMed  Google Scholar 

  11. Ooi SL, Martinez ME, Li CI. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat. 2011;127(3):729–38. https://doi.org/10.1007/s10549-010-1191-6.

    Article  PubMed  Google Scholar 

  12. Iqbal J, Ginsburg O, Rochon PA, Sun P, Narod SA. Differences in breast cancer stage at diagnosis and cancer-specific survival by race and ethnicity in the United States. JAMA. 2015;313(2):165–73. https://doi.org/10.1001/jama.2014.17322.

    Article  CAS  PubMed  Google Scholar 

  13. • Alvidrez J, Castille D, Laude-Sharp M, Rosario A, Tabor D. The National Institute on Minority Health and Health Disparities Research Framework. Am J Public Health. 2019;109(S1):S16–20. https://doi.org/10.2105/AJPH.2018.304883Multidimensional/multilevel framework proposed by NIMHD to think about health disparities.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Conomos MP, Laurie CA, Stilp AM, Gogarten SM, McHugh CP, Nelson SC, et al. Genetic diversity and association studies in US Hispanic/Latino populations: applications in the Hispanic Community Health Study/Study of Latinos. Am J Hum Genet. 2016;98(1):165–84. https://doi.org/10.1016/j.ajhg.2015.12.001.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. G Soares-Souza, V Borda, F Kehdy & E Tarazona-Santos. Admixture, genetics and complex diseases in Latin Americans and US Hispanics. Current Genetic Medicine Reports. 2018.

  16. Bryc K, Velez C, Karafet T, Moreno-Estrada A, Reynolds A, Auton A, et al. Colloquium paper: genome-wide patterns of population structure and admixture among Hispanic/Latino populations. Proc Natl Acad Sci U S A. 2010;107(Suppl 2):8954–61. https://doi.org/10.1073/pnas.0914618107.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Ruiz-Linares A, Adhikari K, Acuna-Alonzo V, Quinto-Sanchez M, Jaramillo C, Arias W, et al. Admixture in Latin America: geographic structure, phenotypic diversity and self-perception of ancestry based on 7,342 individuals. PLoS Genet. 2014;10(9):e1004572. https://doi.org/10.1371/journal.pgen.1004572.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  18. Avena S, Via M, Ziv E, Pérez-Stable EJ, Gignoux CR, Dejean C, et al. Heterogeneity in genetic admixture across different regions of Argentina. PLoS One. 2012;7(4):e34695. https://doi.org/10.1371/journal.pone.0034695.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Moreno-Estrada A, Gignoux CR, Fernández-López JC, Zakharia F, Sikora M, Contreras AV, et al. Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. Science. 2014;344(6189):1280–5. https://doi.org/10.1126/science.1251688.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Homburger JR, Moreno-Estrada A, Gignoux CR, Nelson D, Sanchez E, Ortiz-Tello P, et al. Genomic insights into the ancestry and demographic history of South America. PLoS Genet. 2015;11(12):e1005602. https://doi.org/10.1371/journal.pgen.1005602.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Society AAC. Cancer Facts & Figures for Hispanics/Latinos 2018–2020. 2018.

  22. Di Sibio A, Abriata G, Forman D, Sierra MS. Female breast cancer in Central and South America. Cancer Epidemiol. 2016;44(Suppl 1):S110–S20. https://doi.org/10.1016/j.canep.2016.08.010.

    Article  PubMed  Google Scholar 

  23. Fejerman L, John EM, Huntsman S, Beckman K, Choudhry S, Perez-Stable E, et al. Genetic ancestry and risk of breast cancer among U.S. Latinas. Cancer Res. 2008;68(23):9723–8. https://doi.org/10.1158/0008-5472.CAN-08-2039.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Fejerman L, Romieu I, John EM, Lazcano-Ponce E, Huntsman S, Beckman KB, et al. European ancestry is positively associated with breast cancer risk in Mexican women. Cancer Epidemiol Biomark Prev. 2010;19(4):1074–82. https://doi.org/10.1158/1055-9965.EPI-09-1193.

    Article  Google Scholar 

  25. Hoffman J, Fejerman L, Hu D, Huntsman S, Li M, John EM, et al. Identification of novel common breast cancer risk variants at the 6q25 locus among Latinas. Breast Cancer Res. 2019;21(1):3. https://doi.org/10.1186/s13058-018-1085-9.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Herrick JS, Baumgartner KB, et al. Genetic variation in genes involved in hormones, inflammation and energetic factors and breast cancer risk in an admixed population. Carcinogenesis. 2012;33(8):1512–21. https://doi.org/10.1093/carcin/bgs163.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Fejerman L, Stern MC, Ziv E, John EM, Torres-Mejia G, Hines LM, et al. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women. Carcinogenesis. 2013;34(8):1787–93. https://doi.org/10.1093/carcin/bgt110.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Slattery ML, Hines LH, Lundgreen A, Baumgartner KB, Wolff RK, Stern MC, et al. Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study. Cancer Causes Control. 2014;25(9):1211–25. https://doi.org/10.1007/s10552-014-0426-y.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP, Stern MC, et al. Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study. Int J Cancer. 2014;134(3):629–44. https://doi.org/10.1002/ijc.28377.

    Article  CAS  PubMed  Google Scholar 

  30. Slattery ML, John EM, Stern MC, Herrick J, Lundgreen A, Giuliano AR, et al. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat. 2013;140(3):587–601. https://doi.org/10.1007/s10549-013-2644-5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Armstrong N, Ryder S, Forbes C, Ross J, Quek RG. A systematic review of the international prevalence of. Clin Epidemiol. 2019;11:543–61. https://doi.org/10.2147/CLEP.S206949.

    Article  PubMed  PubMed Central  Google Scholar 

  32. • Lynce F, Graves KD, Jandorf L, Ricker C, Castro E, Moreno L, et al. Genomic disparities in breast cancer among Latinas. Cancer Control. 2016;23(4):359–72 Comprehensive review on genomic disparities in breast cancer among Latinas.

    Article  PubMed  Google Scholar 

  33. Cruz-Correa M, Pérez-Mayoral J, Dutil J, Echenique M, Mosquera R, Rivera-Román K, et al. Hereditary cancer syndromes in Latino populations: genetic characterization and surveillance guidelines. Hered Cancer Clin Pract. 2017;15:3. https://doi.org/10.1186/s13053-017-0063-z.

    Article  PubMed  PubMed Central  Google Scholar 

  34. • Dutil J, Golubeva VA, Pacheco-Torres AL, Diaz-Zabala HJ, Matta JL, Monteiro AN. The spectrum of BRCA1 and BRCA2 alleles in Latin America and the Caribbean: a clinical perspective. Breast Cancer Res Treat. 2015;154(3):441–53. https://doi.org/10.1007/s10549-015-3629-3Comprehensive description of previous studies reporting on the spectrum of BRCA alleles in Latin America and the Caribbean.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Zavala VA, Serrano-Gomez SJ, Dutil J, Fejerman L. Genetic epidemiology of breast cancer in Latin America. Genes (Basel). 2019;10(2):E153. https://doi.org/10.3390/genes10020153.

    Article  CAS  Google Scholar 

  36. John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, et al. Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA. 2007;298(24):2869–76. https://doi.org/10.1001/jama.298.24.2869.

    Article  CAS  PubMed  Google Scholar 

  37. Weitzel JN, Clague J, Martir-Negron A, Ogaz R, Herzog J, Ricker C, et al. Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network. J Clin Oncol. 2013;31(2):210–6. https://doi.org/10.1200/JCO.2011.41.0027.

    Article  CAS  PubMed  Google Scholar 

  38. Oliver J, Quezada Urban R, Franco Cortés CA, Díaz Velásquez CE, Montealegre Paez AL, Pacheco-Orozco RA, et al. Latin American Study of Hereditary Breast and Ovarian Cancer. Front Oncol. 2019;9:1429. https://doi.org/10.3389/fonc.2019.01429.

    Article  PubMed  PubMed Central  Google Scholar 

  39. • Weitzel JN, Neuhausen SL, Adamson A, Tao S, Ricker C, Maoz A, et al. Pathogenic and likely pathogenic variants in PALB2, CHEK2, and other known breast cancer susceptibility genes among 1054 BRCA-negative Hispanics with breast cancer. Cancer. 2019;125(16):2829–36. https://doi.org/10.1002/cncr.32083Description of rare high penetrance mutations among BRCA-negative Hispanics with breast cancer.

    Article  CAS  PubMed  Google Scholar 

  40. Keegan TH, John EM, Fish KM, Alfaro-Velcamp T, Clarke CA, Gomez SL. Breast cancer incidence patterns among California Hispanic women: differences by nativity and residence in an enclave. Cancer Epidemiol Biomarkers Prevent : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 2010;19(5):1208–18. https://doi.org/10.1158/1055-9965.EPI-10-0021.

    Article  Google Scholar 

  41. John EM, Phipps AI, Davis A, Koo J. Migration history, acculturation, and breast cancer risk in Hispanic women. Cancer Epidemiol Biomark Prev. 2005;14(12):2905–13. https://doi.org/10.1158/1055-9965.EPI-05-0483.

    Article  Google Scholar 

  42. • Pinheiro PS, Sherman RL, Trapido EJ, Fleming LE, Huang Y, Gomez-Marin O, et al. Cancer incidence in first generation U.S. Hispanics: Cubans, Mexicans, Puerto Ricans, and new Latinos. Cancer Epidemiol Biomark Prev. 2009;18(8):2162–9. https://doi.org/10.1158/1055-9965.EPI-09-0329Showed how cancer rates vary among Hispanic subpopulations by country of origin and immigration status.

    Article  Google Scholar 

  43. Conroy SM, Shariff-Marco S, Koo J, Yang J, Keegan TH, Sangaramoorthy M, et al. Racial/ethnic differences in the impact of neighborhood social and built environment on breast cancer risk: the Neighborhoods and Breast Cancer Study. Cancer Epidemiol Biomark Prev. 2017;26(4):541–52. https://doi.org/10.1158/1055-9965.EPI-16-0935.

    Article  Google Scholar 

  44. Dubowitz T, Subramanian SV, Acevedo-Garcia D, Osypuk TL, Peterson KE. Individual and neighborhood differences in diet among low-income foreign and U.S.-born women. Womens Health Issues. 2008;18(3):181–90. https://doi.org/10.1016/j.whi.2007.11.001.

    Article  PubMed  PubMed Central  Google Scholar 

  45. McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159–69. https://doi.org/10.1158/1055-9965.EPI-06-0034.

    Article  Google Scholar 

  46. Tehranifar P, Rodriguez CB, April-Sanders AK, Desperito E, Schmitt KM. Migration history, language acculturation, and mammographic breast density. Cancer Epidemiol Biomark Prev. 2018;27(5):566–74. https://doi.org/10.1158/1055-9965.EPI-17-0885.

    Article  Google Scholar 

  47. Akinyemiju TF, Genkinger JM, Farhat M, Wilson A, Gary-Webb TL, Tehranifar P. Residential environment and breast cancer incidence and mortality: a systematic review and meta-analysis. BMC Cancer. 2015;15:191. https://doi.org/10.1186/s12885-015-1098-z.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Yost K, Perkins C, Cohen R, Morris C, Wright W. Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control. 2001;12(8):703–11. https://doi.org/10.1023/a:1011240019516.

    Article  CAS  PubMed  Google Scholar 

  49. Osypuk TL, Diez Roux AV, Hadley C, Kandula NR. Are immigrant enclaves healthy places to live? The multi-ethnic study of atherosclerosis. Soc Sci Med. 2009;69(1):110–20. https://doi.org/10.1016/j.socscimed.2009.04.010.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Pruitt SL, Tiro JA, Xuan L, Lee SJ. Hispanic and immigrant paradoxes in U.S. breast cancer mortality: impact of neighborhood poverty and Hispanic density. Int J Environ Res Public Health. 2016;13(12):E1238. https://doi.org/10.3390/ijerph13121238.

    Article  PubMed  Google Scholar 

  51. Pinheiro PS, Williams M, Miller EA, Easterday S, Moonie S, Trapido EJ. Cancer survival among Latinos and the Hispanic paradox. Cancer Causes Control. 2011;22(4):553–61. https://doi.org/10.1007/s10552-011-9727-6.

    Article  PubMed  Google Scholar 

  52. Li CI, Malone KE, Daling JR. Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med. 2003;163(1):49–56. https://doi.org/10.1001/archinte.163.1.49.

    Article  PubMed  Google Scholar 

  53. Rodriguez-Alcalá ME, Qin H, Jeanetta S. The role of acculturation and social capital in access to health care: a meta-study on Hispanics in the US. J Community Health. 2019;44(6):1224–52. https://doi.org/10.1007/s10900-019-00692-z.

    Article  PubMed  Google Scholar 

  54. Press R, Carrasquillo O, Sciacca RR, Giardina EG. Racial/ethnic disparities in time to follow-up after an abnormal mammogram. J Women's Health (Larchmt). 2008;17(6):923–30. https://doi.org/10.1089/jwh.2007.0402.

    Article  Google Scholar 

  55. Goldman LE, Walker R, Hubbard R, Kerlikowske K, Consortium BCS. Timeliness of abnormal screening and diagnostic mammography follow-up at facilities serving vulnerable women. Med Care. 2013;51(4):307–14. https://doi.org/10.1097/MLR.0b013e318280f04c.

    Article  PubMed  PubMed Central  Google Scholar 

  56. Banegas MP, Tao L, Altekruse S, Anderson WF, John EM, Clarke CA, et al. Heterogeneity of breast cancer subtypes and survival among Hispanic women with invasive breast cancer in California. Breast Cancer Res Treat. 2014;144(3):625–34. https://doi.org/10.1007/s10549-014-2882-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  57. Hines LM, Risendal B, Byers T, Mengshol S, Lowery J, Singh M. Ethnic disparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic white women. J Women's Health (Larchmt). 2011;20(10):1543–50. https://doi.org/10.1089/jwh.2010.2558.

    Article  Google Scholar 

  58. Howlader N, Altekruse SF, Li CI, Chen VW, Clarke CA, Ries LA, et al. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status. J Natl Cancer Inst. 2014;106(5):dju055. https://doi.org/10.1093/jnci/dju055.

    Article  PubMed  PubMed Central  Google Scholar 

  59. Parise CA, Bauer KR, Caggiano V. Variation in breast cancer subtypes with age and race/ethnicity. Crit Rev Oncol Hematol. 2010;76(1):44–52. https://doi.org/10.1016/j.critrevonc.2009.09.002.

    Article  PubMed  Google Scholar 

  60. Serrano-Gomez SJ, Fejerman L, Zabaleta J. Breast cancer in Latinas: a focus on intrinsic subtypes distribution. Cancer Epidemiol Biomark Prev. 2018;27(1):3–10. https://doi.org/10.1158/1055-9965.EPI-17-0420.

    Article  Google Scholar 

  61. Wells KJ, Roetzheim RG. Health disparities in receipt of screening mammography in Latinas: a critical review of recent literature. Cancer Control. 2007;14(4):369–79. https://doi.org/10.1177/107327480701400407.

    Article  PubMed  Google Scholar 

  62. Society AC. Breast Cancer Facts & Figures 2017–2018. 2017.

  63. Purc-Stephenson RJ, Gorey KM. Lower adherence to screening mammography guidelines among ethnic minority women in America: a meta-analytic review. Prev Med. 2008;46(6):479–88. https://doi.org/10.1016/j.ypmed.2008.01.001.

    Article  PubMed  PubMed Central  Google Scholar 

  64. Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, et al. Time to diagnosis and breast cancer stage by race/ethnicity. Breast Cancer Res Treat. 2012;136(3):813–21. https://doi.org/10.1007/s10549-012-2304-1.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Molina Y, Plascak JJ, Patrick DL, Bishop S, Coronado GD, Beresford SA. Neighborhood predictors of mammography barriers among US-based Latinas. J Racial Ethn Health Disparities. 2017;4(2):233–42. https://doi.org/10.1007/s40615-016-0222-3.

    Article  PubMed  Google Scholar 

  66. Clarke TC, Endeshaw M, Duran D, Saraiya M. Breast cancer screening among women by nativity, birthplace, and length of time in the United States. Natl Health Stat Report. 2019;129:1–15.

    Google Scholar 

  67. Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57. https://doi.org/10.1093/jnci/94.5.334.

    Article  PubMed  Google Scholar 

  68. Chen L, Li CI. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status. Cancer Epidemiol Biomark Prev. 2015;24(11):1666–72. https://doi.org/10.1158/1055-9965.EPI-15-0293.

    Article  CAS  Google Scholar 

  69. Wu XC, Lund MJ, Kimmick GG, Richardson LC, Sabatino SA, Chen VW, et al. Influence of race, insurance, socioeconomic status, and hospital type on receipt of guideline-concordant adjuvant systemic therapy for locoregional breast cancers. J Clin Oncol. 2012;30(2):142–50. https://doi.org/10.1200/JCO.2011.36.8399.

    Article  PubMed  Google Scholar 

  70. Friese CR, Pini TM, Li Y, Abrahamse PH, Graff JJ, Hamilton AS, et al. Adjuvant endocrine therapy initiation and persistence in a diverse sample of patients with breast cancer. Breast Cancer Res Treat. 2013;138(3):931–9. https://doi.org/10.1007/s10549-013-2499-9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  71. Warner ET, Tamimi RM, Hughes ME, Ottesen RA, Wong YN, Edge SB, et al. Racial and ethnic differences in breast cancer survival: mediating effect of tumor characteristics and sociodemographic and treatment factors. J Clin Oncol. 2015;33(20):2254–61. https://doi.org/10.1200/JCO.2014.57.1349.

    Article  PubMed  PubMed Central  Google Scholar 

  72. Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol. 2011;29(18):2534–42. https://doi.org/10.1200/JCO.2010.33.3179.

    Article  PubMed  PubMed Central  Google Scholar 

  73. Daly B, Olopade OI, Hou N, Yao K, Winchester DJ, Huo D. Evaluation of the quality of adjuvant endocrine therapy delivery for breast cancer care in the United States. JAMA Oncol. 2017;3(7):928–35. https://doi.org/10.1001/jamaoncol.2016.6380.

    Article  PubMed  PubMed Central  Google Scholar 

  74. Farias AJ, Du XL. Ethnic differences in initiation and timing of adjuvant endocrine therapy among older women with hormone receptor-positive breast cancer enrolled in Medicare Part D. Med Oncol. 2016;33(2):19. https://doi.org/10.1007/s12032-016-0732-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI, et al. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2012;131(2):607–17. https://doi.org/10.1007/s10549-011-1762-1.

    Article  CAS  PubMed  Google Scholar 

  76. Biggers A, Shi Y, Charlson J, Smith EC, Smallwood AJ, Nattinger AB, et al. Medicare D subsidies and racial disparities in persistence and adherence with hormonal therapy. J Clin Oncol. 2016;34(36):4398–404. https://doi.org/10.1200/JCO.2016.67.3350.

    Article  PubMed  PubMed Central  Google Scholar 

  77. (EBCTCG) EBCTCG. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717. https://doi.org/10.1016/S0140-6736(05)66544-0.

    Article  CAS  Google Scholar 

  78. Jara Sánchez C, Ruiz A, Martín M, Antón A, Munárriz B, Plazaola A, et al. Influence of timing of initiation of adjuvant chemotherapy over survival in breast cancer: a negative outcome study by the Spanish Breast Cancer Research Group (GEICAM). Breast Cancer Res Treat. 2007;101(2):215–23. https://doi.org/10.1007/s10549-006-9282-0.

    Article  PubMed  Google Scholar 

  79. Buzdar AU, Smith TL, Powell KC, Blumenschein GR, Gehan EA. Effect of timing of initiation of adjuvant chemotherapy on disease-free survival in breast cancer. Breast Cancer Res Treat. 1982;2(2):163–9. https://doi.org/10.1007/bf01806452.

    Article  CAS  PubMed  Google Scholar 

  80. Hershman DL, Wang X, McBride R, Jacobson JS, Grann VR, Neugut AI. Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women. Breast Cancer Res Treat. 2006;99(3):313–21. https://doi.org/10.1007/s10549-006-9206-z.

    Article  CAS  PubMed  Google Scholar 

  81. Colleoni M, Bonetti M, Coates AS, Castiglione-Gertsch M, Gelber RD, Price K, et al. Early start of adjuvant chemotherapy may improve treatment outcome for premenopausal breast cancer patients with tumors not expressing estrogen receptors. The International Breast Cancer Study Group. J Clin Oncol. 2000;18(3):584–90. https://doi.org/10.1200/JCO.2000.18.3.584.

    Article  CAS  PubMed  Google Scholar 

  82. Nurgalieva ZZ, Franzini L, Morgan RO, Vernon SW, Liu CC, Du XL. Impact of timing of adjuvant chemotherapy initiation and completion after surgery on racial disparities in survival among women with breast cancer. Med Oncol. 2013;30(1):419. https://doi.org/10.1007/s12032-012-0419-1.

    Article  CAS  PubMed  Google Scholar 

  83. Fedewa SA, Ward EM, Stewart AK, Edge SB. Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006. J Clin Oncol. 2010;28(27):4135–41. https://doi.org/10.1200/JCO.2009.27.2427.

    Article  PubMed  Google Scholar 

  84. Katz SJ, Wallner LP, Abrahamse PH, Janz NK, Martinez KA, Shumway DA, et al. Treatment experiences of Latinas after diagnosis of breast cancer. Cancer. 2017;123(16):3022–30. https://doi.org/10.1002/cncr.30702.

    Article  PubMed  Google Scholar 

  85. Ramirez A, Perez-Stable E, Penedo F, Talavera G, Carrillo JE, Fernández M, et al. Reducing time-to-treatment in underserved Latinas with breast cancer: the Six Cities Study. Cancer. 2014;120(5):752–60. https://doi.org/10.1002/cncr.28450.

    Article  PubMed  Google Scholar 

  86. Power EJ, Chin ML, Haq MM. Breast cancer incidence and risk reduction in the Hispanic population. Cureus. 2018;10(2):e2235. https://doi.org/10.7759/cureus.2235.

    Article  PubMed  PubMed Central  Google Scholar 

  87. Akinyemiju T, Moore JX, Ojesina AI, Waterbor JW, Altekruse SF. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources. Breast Cancer Res Treat. 2016;157(3):575–86. https://doi.org/10.1007/s10549-016-3840-x.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  88. Siegel RL, Fedewa SA, Miller KD, Goding-Sauer A, Pinheiro PS, Martinez-Tyson D, et al. Cancer statistics for Hispanics/Latinos, 2015. CA Cancer J Clin. 2015;65(6):457–80. https://doi.org/10.3322/caac.21314.

    Article  PubMed  Google Scholar 

  89. Martínez ME, Gomez SL, Tao L, Cress R, Rodriguez D, Unkart J, et al. Contribution of clinical and socioeconomic factors to differences in breast cancer subtype and mortality between Hispanic and non-Hispanic white women. Breast Cancer Res Treat. 2017;166(1):185–93. https://doi.org/10.1007/s10549-017-4389-z.

    Article  PubMed  PubMed Central  Google Scholar 

  90. Ellis L, Canchola AJ, Spiegel D, Ladabaum U, Haile R, Gomez SL. Racial and ethnic disparities in cancer survival: the contribution of tumor, sociodemographic, institutional, and neighborhood characteristics. J Clin Oncol. 2018;36(1):25–33. https://doi.org/10.1200/JCO.2017.74.2049.

    Article  CAS  PubMed  Google Scholar 

  91. Warnecke RB, Campbell RT, Vijayasiri G, Barrett RE, Rauscher GH. Multilevel examination of health disparity: the role of policy implementation in neighborhood context, in patient resources, and in healthcare facilities on later stage of breast cancer diagnosis. Cancer Epidemiol Biomark Prev. 2019;28(1):59–66. https://doi.org/10.1158/1055-9965.EPI-17-0945.

    Article  Google Scholar 

  92. Guan A, Lichtensztajn D, Oh D, Jain J, Tao L, Hiatt RA, et al. Breast cancer in San Francisco: disentangling disparities at the neighborhood level. Cancer Epidemiol Biomark Prev. 2019;28(12):1968–76. https://doi.org/10.1158/1055-9965.EPI-19-0799.

    Article  Google Scholar 

  93. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;406(6797):747–52. https://doi.org/10.1038/35021093.

    Article  CAS  PubMed  Google Scholar 

  94. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF, et al. The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics. 2006;7:96. https://doi.org/10.1186/1471-2164-7-96.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. Network CGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61–70. https://doi.org/10.1038/nature11412.

    Article  CAS  Google Scholar 

  96. Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, et al. Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype. Clin Cancer Res. 2008;14(5):1368–76. https://doi.org/10.1158/1078-0432.CCR-07-1658.

    Article  CAS  PubMed  Google Scholar 

  97. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z, et al. Basal-like subtype of invasive breast carcinoma immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res. 2004;10:5367–74.

    Article  CAS  PubMed  Google Scholar 

  98. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98(19):10869–74. https://doi.org/10.1073/pnas.191367098.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  99. Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–67. https://doi.org/10.1172/JCI45014.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  100. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al. Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. J Am Med Assoc. 2006;295(21):2492–502.

    Article  CAS  Google Scholar 

  101. Parise CA, Caggiano V. Disparities in race/ethnicity and socioeconomic status: risk of mortality of breast cancer patients in the California Cancer Registry, 2000-2010. BMC Cancer. 2013;13:449. https://doi.org/10.1186/1471-2407-13-449.

    Article  PubMed  PubMed Central  Google Scholar 

  102. Fejerman L, Serrano-Gómez S.J, Tamayo L. Breast cancer risk and mortality in women of Latin American Origin. In: Trapido AGREJ, editor. Advancing the Science of Cancer in Latinos Springer Open; 2020.

  103. Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27(8):1160–7. https://doi.org/10.1200/JCO.2008.18.1370.

    Article  PubMed  PubMed Central  Google Scholar 

  104. Sweeney C, Bernard PS, Factor RE, Kwan ML, Habel LA, Quesenberry CP Jr, et al. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomark Prev. 2014;23(5):714–24. https://doi.org/10.1158/1055-9965.EPI-13-1023.

    Article  CAS  Google Scholar 

  105. • Marker KM, Zavala VA, Vidaurre T, Lott PC, Vásquez JN, Casavilca-Zambrano S, et al. Human epidermal growth factor receptor 2–positive breast cancer is associated with Indigenous American ancestry in Latin American Women. Cancer Res. 2020. https://doi.org/10.1158/0008-5472.can-19-3659This study reported for the first time an association between Indigenous American ancestry and an increased risk for HER2-positive tumors in Latina women.

  106. Serrano-Gómez SJ, Sanabria-Salas MC, Garay J, Baddoo MC, Hernández-Suarez G, Mejía JC, et al. Ancestry as a potential modifier of gene expression in breast tumors from Colombian women. PLoS One. 2017;12(8):e0183179. https://doi.org/10.1371/journal.pone.0183179.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Grupo de investigación en biología del cáncer, Instituto Nacional de Cancerología, Bogotá, Colombia

    Silvia J. Serrano-Gomez

  2. Subdirección de Investigaciones - Instituto Nacional de Cancerología, Bogotá, Colombia

    Maria Carolina Sanabria-Salas

  3. Department of Medicine, Division of General Internal Medicine, University of California San Francisco, 550 16th Street, San Francisco, CA, 94143, USA

    Laura Fejerman

Authors
  1. Silvia J. Serrano-Gomez
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Maria Carolina Sanabria-Salas
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Laura Fejerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Laura Fejerman.

Ethics declarations

Conflict of Interest

The authors declare that they have no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Breast Cancer Disparities

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Serrano-Gomez, S.J., Sanabria-Salas, M.C. & Fejerman, L. Breast Cancer Health Disparities in Hispanics/Latinas. Curr Breast Cancer Rep 12, 175–184 (2020). https://doi.org/10.1007/s12609-020-00370-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12609-020-00370-3

Keywords

Search

Navigation